FFIV vs PLX · P/E 32, rev $3.09B vs P/E 31, rev $53.6M
F5 Networks Inc (FFIV) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the FFIV and PLX stock pages for the full models.
Not investment advice.